Trial Profile
A Real-Life, Multicenter Study to Evaluate The Safety and Efficacy of The Simeprevir + Sofosbuvir Combination In Patients With Genotype 1 Hepatitis C Recurrence After Liver Transplant.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Aug 2015
Price :
$35
*
At a glance
- Drugs Simeprevir (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 11 Aug 2015 New trial record